Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Targeted Drug Delivery dealmaking

2.1. Introduction
2.2. Targeted Drug Delivery partnering over the years
2.3. Most active Targeted Drug Delivery dealmakers
2.4. Targeted Drug Delivery partnering by deal type
2.5. Targeted Drug Delivery partnering by therapy area
2.6. Deal terms for Targeted Drug Delivery partnering
2.6.1 Targeted Drug Delivery partnering headline values
2.6.2 Targeted Drug Delivery deal upfront payments7
2.6.3 Targeted Drug Delivery deal milestone payments
2.6.4 Targeted Drug Delivery royalty rates

Chapter 3 – Leading Targeted Drug Delivery deals

3.1. Introduction
3.2. Top Targeted Drug Delivery deals by value

Chapter 4 – Most active Targeted Drug Delivery dealmakers

4.1. Introduction
4.2. Most active Targeted Drug Delivery dealmakers
4.3. Most active Targeted Drug Delivery partnering company profiles

Chapter 5 – Targeted Drug Delivery contracts dealmaking directory

5.1. Introduction
5.2. Targeted Drug Delivery contracts dealmaking directory

Chapter 6 – Targeted Drug Delivery dealmaking by technology type

Chapter 7 – Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 – Targeted Drug Delivery deals by company A-Z

Appendix 2 – Targeted Drug Delivery deals by stage of development

Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation

Appendix 3 – Targeted Drug Delivery deals by deal type

Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty

Appendix 4 – Targeted Drug Delivery deals by therapy area

Appendix 5 –Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Targeted Drug Delivery partnering since 2014
Figure 2: Active Targeted Drug Delivery dealmaking activity– 2014 to 2019
Figure 3: Targeted Drug Delivery partnering by deal type since 2014
Figure 4: Targeted Drug Delivery partnering by disease type since 2014
Figure 5: Targeted Drug Delivery deals with a headline value
Figure 6: Targeted Drug Delivery deals with an upfront value
Figure 7: Targeted Drug Delivery deals with a milestone value
Figure 8: Targeted Drug Delivery deals with a royalty rate value
Figure 9: Top Targeted Drug Delivery deals by value since 2014
Figure 10: Most active Targeted Drug Delivery dealmakers 2014 to 2019
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events